depression, antidepressant use and mortality in later life the health in men study抑郁症,抗抑郁药物使用和死亡率在晚年健康男性的研究.pdfVIP

  • 2
  • 0
  • 约7.22万字
  • 约 9页
  • 2017-09-01 发布于上海
  • 举报

depression, antidepressant use and mortality in later life the health in men study抑郁症,抗抑郁药物使用和死亡率在晚年健康男性的研究.pdf

depression, antidepressant use and mortality in later life the health in men study抑郁症,抗抑郁药物使用和死亡率在晚年健康男性的研究

Depression, Antidepressant Use and Mortality in Later Life: The Health in Men Study Osvaldo P. Almeida1,2,3*, Helman Alfonso1,2, Graeme J. Hankey4,5, Leon Flicker1,5,6 1 Western Australia Centre for Health Ageing, Centre for Medical Research, University of Western Australia, Perth, Western Australia, Australia, 2 School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, Western Australia, Australia, 3 Department of Psychiatry, Royal Perth Hospital, Perth, Western Australia, Australia, 4 Stroke Unit, Royal Perth Hospital, Perth, Western Australia, Australia, 5 School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia, 6 Department of Geriatric Medicine, Royal Perth Hospital, Perth, Western Australia, Australia Abstract Context: Depression is associated with increased mortality, but it is unclear if this relationship is dose-dependent and if it can be modified by treatment with antidepressants. Objective: To determine if (1) the association between depression and mortality is independent of other common potential causes of death in later life, (2) there is a dose-response relationship between increasing severity of depression and mortality rates, and (3) the use of antidepressant drugs reduces mortality rates. Methods: Cohort study of 5,276 community-dwelling men aged 68–88 years living in Perth, Australia. We used the Geriatric Depression Scale 15-items (GDS-15) to ascertain the presence and severity of depression. GDS-15$7 indicates the presence of clinically significant depression. Men were also grouped according to the severity of symptoms: ‘‘no symptoms’’ (GDS- 15 = 0), ‘‘questionable’’ (1#GDS-15#4), ‘‘mild to moderate’’ (5#GDS-15#9), and ‘‘severe’’ (GDS-15$10). Participants listed all medications used regularly. We used the Western Australian Data Linkage System to monitor mortality. Res

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档